Latest Imricor Medical Systems (ASX:IMR) News

Page 3

Page 3 of 3

Imricor Accelerates MRI-Guided Cardiac Ablations with FDA Success and 840% Revenue Jump

Imricor Advances MRI-Guided Cardiac Ablations with Regulatory Wins and Revenue Surge

Imricor Medical Systems reports strong Q4 CY24 progress with successful FDA review, CE Mark submissions, and an 840% jump in consumables revenue, positioning the company for expanded global market penetration.

Ada Torres

23 Jan 2025